Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rituximab Plus CHOP Given Every Two Weeks With Sargramostim in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

NCT00599170 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT00599170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00599170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rituximab Plus CHOP Given Every Two Weeks With Sargramostim in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Lead sponsor
University of Southern California
Phase
Phase 2
Overall status
Completed
Start date
January 10, 2008
Completion date
January 10, 2021
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse, large b-cell, lymphoma